Chinese regulatory authorities have granted Boehringer Ingelheim Vetmedica GmbH market authorization for ingelvac CircoFLEX, a vaccine against porcine circovirus disease. The vaccine contains a purified circo-antigen with ImpranFLEX adjuvant. It is licensed as a single-shot vaccine recommended for administration around weaning. The vaccine was previously approved for use in North America, Europe, Australia, South Africa and parts of South America and Asia.
